Category

Press Release
•2020年3月5日

Molecular Med TRI-CON 2020

Date: March 1-4, 2020 Location: Moscone South Conventio...
•2020年2月21日

“肺”常战“疫”，慧渡医疗携手基因产业同行 – 抗疫灭毒联合行动倡议

新型冠状病毒疫情牵动人心，肺炎疫情仍在升级。 17年前的非典，确定病原体并进行冠状病毒RNA测序，中国落后了。...
•2020年1月8日

慧渡医疗与默克将在美国2020AACR液态活检专题学术会议上联合发表液态活检最新科研进展

通过ctDNA和cfRNA液态活检技术对肿瘤驱动基因变异进行全方位分子机理研究，对监测晚期结直肠癌耐药性和疾病...
•2019年9月27日

Predicine Receives CAP Accreditation for its Precision Cancer Testing Laboratory in Shanghai

Predicine, a molecular insights company with business o...
•2019年5月10日

Predicine Partners with FMD to Accelerate Biomarker-Driven Clinical Trials and Regulatory Approvals in the U.S. and China

Predicine today announced a strategic partnership with ...
•2018年12月3日

Congruence Study Between Two ctDNA Liquid Biopsy Testing in mBC Patients and Prognostic Value in Combination with CTCs, Investigators to Report at SABCS 2018

Liquid biopsies are being widely studied as a minimally...
•2018年10月18日

Predicine Establishes Dual CAP Accreditation for its Genomic Sequencing Laboratories in US and China to Support Global Clinical Trials

Predicine, a molecular insights company, announced toda...
•2018年9月20日

Predicine and Flagship Biosciences Partner to Support Global Biomarker Development

Predicine and Flagship Biosciences are excited to annou...
•2018年8月22日

Predicine and Kintor Pharma to Present ctDNA & ctRNA Biomarker Data for PhI/II Clinical Trial in mCRPC at ESMO 2018

Predicine and Kintor Pharma today announced that new da...
•2018年7月3日

Predicine and Kintor Pharmaceuticals Collaborate on Precision Oncology Clinical Trials and Companion Diagnostics Development

Predicine, a precision medicine company based in Silico...
1 … 17 18 19 20